DarioHealth (DRIO) Director Dennis Matheis Receives Award

What Happened
Dennis Matheis, a director of DarioHealth Corp. (DRIO), received a grant of 44,000 restricted shares on 2026-09-24. The grant price is reported as $0.00 (no cash paid at grant), so the reported acquisition value is $0. The award is a restricted share award subject to vesting.

Key Details

• Transaction date: 2026-09-24 (Form 4 filed 2026-09-28; filing appears timely)
• Transaction code: A (award/grant)
• Shares granted: 44,000 restricted shares at $0.00 per share (total reported acquisition value $0)
• Shares owned after transaction: not specified in the filing
• Footnote: The restricted shares vest on the second anniversary of the grant date (per footnote F1)

Context
Restricted share awards are a common form of director compensation and are subject to vesting conditions; they do not represent an immediate market purchase or sale. Because the shares are subject to future vesting, this grant should be viewed as compensation rather than a direct bullish purchase by the insider.